ENZ logo

Enzo Biochem (ENZ) Company Overview

Profile

Full Name:

Enzo Biochem, Inc.

Sector:

Healthcare

Industry:

Diagnostics & Research

Country:

United States

IPO:

June 12, 1980

Indexes:

Not included

Website:

http://www.enzo.com

Description:

Enzo Biochem, Inc. is a biotechnology company that develops and sells products for life sciences research and diagnostics. They focus on innovative solutions in molecular biology, genomics, and diagnostics to help scientists and healthcare professionals improve health and understand diseases better.

Key Details

Price

$0.46

Market Cap

$24.23 M(Small cap)

Last Dividend

$0.10

TTM Dividend Yield

21.56%

Annual Revenue

$31.91 M(+2.72% YoY)

Annual EPS

-$0.51(-224.39% YoY)

PE Ratio

-

Annual ROE

-38.76%

Annual Debt To Equity

0.00

Beta

0.61

Events Calendar

Earnings

Next earnings date:

Mar 13, 2025

Recent quarterly earnings:

Dec 16, 2024

Recent annual earnings:

Oct 14, 2022
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Nov 15, 2024
Splits

Next split:

N/A

Recent split:

Oct 21, 2004

Analyst ratings

Recent major analysts updates

Feb 4, 14 Craig-Hallum
Buy
Jul 2, 13 Sidoti & Co.
Neutral

Screeners with ENZ included

Growing Shares Outstanding
Stocks cheaper than 1 dollar
US stocks
Stocks below SMA 200
Healthcare sector
All stocks
High yield dividend stocks
Stocks with all time high dividends
Top dividend stocks in sectors
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.46
ENZ price is $0.46

Price All-time High

$100.37
ENZ price is currently -99.54% below its historical high of $100.37

Price Analysts Target

-
ENZ price consensus analysts' forecast is unknown

Price Today Change

-2.23%
ENZ price is down -2.23% today

Price YTD Change

-35.07%
ENZ price is down -35.07% since January 1st

Price 3-Year Change

-85.9%
ENZ price is down -85.9% over the past 3 years

Market cap

Market Cap

$24.23 M
ENZ market capitalization is $24.23 million

Market Cap 3-Year Change

-84.81%
ENZ market capitalization is down -84.81% over the past 3 years

Market Cap All-time High

$3.06 B
ENZ market capitalization is currently -99.21% below its historical high of $3.06 billion

Market Cap Sector Rank

27.74%
ENZ market capitalization is higher than 27.74% of companies in Healthcare sector

Technical

Beta

0.61
ENZ beta is 0.61

200-day SMA

$0.98
ENZ price is currently -52.82% below its 200-day simple moving average

14-day RSI

39.11
ENZ 14-day relative strength index is 39.11

30-day Relative Volume

0.30
ENZ 30-day relative volume is 0.30

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.10
ENZ last dividend was $0.10 per share, with an ex-dividend date of November 15, 2024

Next Dividend

-
ENZ next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

-
ENZ annual dividend per share value is unknown

Annual Dividend Per Share Sector Rank

-
ENZ annual dividend per share is unknown

Annual Dividend Per Share 1-Year Change

-
ENZ annual dividend per share 1-year change is unknown

Annual Dividend Per Share 3-Year Change

-
ENZ annual dividend per share 3-year change is unknown

Dividend yield

Annual Dividend Yield

-
ENZ annual dividend yield value is unknown

Annual Dividend Yield Sector Rank

-
ENZ annual dividend yield is unknown

Other

Annual Payout Ratio

-
ENZ annual payout ratio value is unknown

Annual Dividends Paid

-
ENZ annual dividends paid value is unknown

Annual FCF

-$26.80 M
ENZ annual free cash flow is -$26.80 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$31.91 M
ENZ annual revenue is $31.91 million

Annual Revenue Analysts Estimate

-
ENZ annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

+2.72%
ENZ annual revenue is up +2.72% year-on-year

Annual Revenue Sector Rank

42.01%
ENZ annual revenue is higher than 42.01% of companies in Healthcare sector

Profit

Annual Gross Profit

$14.63 M
ENZ annual gross profit is $14.63 million

Annual Gross Margin

45.86%
ENZ annual gross profit margin is 45.86%

Annual Operating Profit

-$12.37 M
ENZ annual operating income is -$12.37 million

Annual Operating Margin

-38.75%
ENZ annual operating profit margin is -38.75%

Annual Net Income

-$26.08 M
ENZ annual net profit is -$26.08 million

Annual Net Margin

-81.73%
ENZ annual net profit margin is -81.73%

EPS

Annual EPS

-$0.51
ENZ annual earnings per share is -$0.51

Annual EPS Analysts Estimate

-
ENZ annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

-224.39%
ENZ annual earnings per share is down -224.39% year-on-year

Annual EPS Sector Rank

70.17%
ENZ annual earnings per share is higher than 70.17% of companies in Healthcare sector

ROA & ROE

Annual ROA

-25.12%
ENZ annual return on assets is -25.12%

Annual ROE

-38.76%
ENZ annual return on equity is -38.76%

EBIT & EBITDA

Annual EBIT

-$9.62 M
ENZ annual earnings before interest & taxes is -$9.62 million

Annual EBITDA

-$8.35 M
ENZ annual EBITDA is -$8.35 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ENZ price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ENZ price to earnings ratio is unknown

PB Ratio

PB Ratio

0.51
ENZ price to book ratio is 0.51

PB Ratio Sector Rank

28.96%
ENZ price to book ratio is higher than 28.96% of companies in Healthcare sector

PS Ratio

PS Ratio

0.80
ENZ price to sales ratio is 0.80

PS Ratio Sector Rank

21.43%
ENZ price to sales ratio is higher than 21.43% of companies in Healthcare sector

Enterprise value

Enterprise Value

-$20.24 M
ENZ enterprise value is -$20.24 million

Enterprise Value Sector Rank

3.34%
ENZ enterprise value is higher than 3.34% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

2.86
ENZ EV/EBITDA is 2.86

EV/EBITDA Sector Rank

77.23%
ENZ EV/EBITDA is higher than 77.23% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.82
ENZ annual current ratio is 2.82

Annual Quick Ratio

2.55
ENZ annual quick ratio is 2.55

Leverage

Annual Debt To Equity

0.00
ENZ annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-48.83
ENZ annual interest coverage ratio is -48.83

Risk & Stability

Piotroski F-Score

2
ENZ piotroski f-score is 2

Altman Z-Score

-3.68
ENZ altman z-score is -3.68

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$85.76 M
ENZ annual total assets is $85.76 million

Annual Non Current Assets

$15.73 M
ENZ annual long term assets is $15.73 million

Annual Current Assets

$70.03 M
ENZ annual total current assets is $70.03 million

Annual Cash & Cash Equivalents

$52.37 M
ENZ annual cash & cash equivalents is $52.37 million

Equity

Annual Book Value

$56.11 M
ENZ annual book value is $56.11 million

Annual Working Capital

$45.24 M
ENZ annual working capital is $45.24 million

Liabilities

Annual Total Liabilities

$29.65 M
ENZ annual total liabilities is $29.65 million

Annual Total Long Term Liabilities

$4.86 M
ENZ annual total long term liabilities is $4.86 million

Annual Current Liabilities

$24.79 M
ENZ annual total current liabilities is $24.79 million

Annual Accounts Payable

$1.38 M
ENZ annual accounts payable is $1.38 million

Debt

Annual Total Debt

$3.51 M
ENZ annual total debt is $3.51 million

Annual Total Debt 1-Year Change

-49.86%
ENZ annual total debt is down -49.86% year-on-year

Annual Long Term Debt

$2.59 M
ENZ annual long term debt is $2.59 million

Annual Short Term Debt

$917.00 K
ENZ annual short term debt is $917.00 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$44.27 M
ENZ annual total expenses is $44.27 million

Annual Operating Expenses

$27.00 M
ENZ annual total operating expenses is $27.00 million

Annual Cost Of Goods Sold

$17.27 M
ENZ annual cost of goods sold is $17.27 million

Annual SGA

$24.36 M
ENZ annual SGA is $24.36 million

Annual D&A

$1.27 M
ENZ annual depreciation & amortization is $1.27 million

Annual Interest Expense

$197.00 K
ENZ annual interest expense is $197.00 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$26.26 M
ENZ annual cash flow from operations is -$26.26 million

Annual CFO 1-Year Change

+28.98%
ENZ annual cash flow from operations is up +28.98% year-on-year

Annual CFI

-$545.00 K
ENZ annual cash flow from investing activities is -$545.00 thousand

Annual CFI 1-Year Change

-100.55%
ENZ annual cash flow from investing activities is down -100.55% year-on-year

Annual CFF

-$4.19 M
ENZ annual cash flow from financing activities is -$4.19 million

Annual CFF 1-Year Change

-272.71%
ENZ annual cash flow from financing activities is down -272.71% year-on-year

Free CashFlow

Annual FCF

-$26.80 M
ENZ annual free cash flow is -$26.80 million

Annual FCF 1-Year Change

+32.54%
ENZ annual free cash flow is up +32.54% year-on-year

CAPEX

Annual CAPEX

$545.00 K
ENZ annual capital expenditures is $545.00 thousand

Annual CAPEX 1-Year Change

-80.25%
ENZ annual capital expenditures is down -80.25% year-on-year

Institutional Ownership

Similar stocks

ENLV logo
Enlivex Therapeutics (ENLV)
DRIO logo
DarioHealth (DRIO)
DRRX logo
DURECT (DRRX)
CMMB logo
Chemomab Therapeutics (CMMB)
EQ logo
Equillium (EQ)
XAIR logo
Beyond Air (XAIR)
RVP logo
Retractable Technologies (RVP)
FNCH logo
Finch Therapeutics (FNCH)
PMN logo
ProMIS Neurosciences (PMN)

FAQ

  • What is the ticker symbol for Enzo Biochem?
  • Does Enzo Biochem pay dividends?
  • What sector is Enzo Biochem in?
  • What industry is Enzo Biochem in?
  • What country is Enzo Biochem based in?
  • When did Enzo Biochem go public?
  • Is Enzo Biochem in the S&P 500?
  • Is Enzo Biochem in the NASDAQ 100?
  • Is Enzo Biochem in the Dow Jones?
  • When was Enzo Biochem's last earnings report?
  • When does Enzo Biochem report earnings?

What is the ticker symbol for Enzo Biochem?

The ticker symbol for Enzo Biochem is NYSE:ENZ

Does Enzo Biochem pay dividends?

Yes, Enzo Biochem pays dividends. The last payment was $0.10, with an ex-dividend date on November 15, 2024

What sector is Enzo Biochem in?

Enzo Biochem is in the Healthcare sector

What industry is Enzo Biochem in?

Enzo Biochem is in the Diagnostics & Research industry

What country is Enzo Biochem based in?

Enzo Biochem is headquartered in United States

When did Enzo Biochem go public?

Enzo Biochem's initial public offering (IPO) was on June 12, 1980

Is Enzo Biochem in the S&P 500?

No, Enzo Biochem is not included in the S&P 500 index

Is Enzo Biochem in the NASDAQ 100?

No, Enzo Biochem is not included in the NASDAQ 100 index

Is Enzo Biochem in the Dow Jones?

No, Enzo Biochem is not included in the Dow Jones index

When was Enzo Biochem's last earnings report?

Enzo Biochem's most recent earnings report was on Dec 16, 2024

When does Enzo Biochem report earnings?

The next expected earnings date for Enzo Biochem is Mar 13, 2025